A post hoc analysis of the CheckMate 040 trial showed that increased CD3+ and CD8+ cell infiltration led to an improvement in the OS in patients treated with nivolumab, but it did not reach statistical significance [ 70 ].
← all excerpts
Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation.
1
—
—